The Mushroom Conference: A Molecular Masterclass

Microdose Psychedelic Insights, along with MagicMed Industries, The Conscious Fund, Wake, and Empyrean present The Mushroom Conference, a three-day virtual conference. On November 20th - 22nd, over 120 experts will guide attendees through the scientific deep dive of the dynamic field of psilocybin and functional mushroom uses, with expert panels and engaging discussions.

The event will explore mushrooms at the intersection of clinical care, research and investment, and feature the world's top researchers, clinicians, companies, advocates and experts. Some overarching areas featured at the Mushroom conference, aimed predominantly at B2B audiences are: Advanced mycological research, Medicinal Mushrooms,  Mycotoxicology,  Food mycology,  Fungal biotechnology,  Industrial mycology,  Medical mycology,  Bacterial-fungal interactions,  Fungal pathogens,  Clinical mycology, Psilocybin research,  Psilocybin clinical studies,  Psilocybin-assisted therapies,  Business and Opportunities, Investment, Consumer brands and Innovations.

Speakers:  Dr. Joseph Tucker Chief Executive Officer, MagicMed Industries Inc., Marshall Tyler Director of Research, Field Trip Psychedelics Inc., Dr. Jillian Hagel COO, MagicMed Industries Inc., Jackie von Salm, PhD, Co-Founder and CSO at Psilera Bioscience, Mohammad Ebrahimzadeh, PhD, MSc Medical Advisor, Dvija Phytoceutical Corp, Dr. Hyder A. Khoja Founder and CSO, Transcendent Therapeutics, Inc., Tonya Papanikolov Founder and CEO of Rainbo, Dustin Robinson Licensed attorney, CPA, and realtor, Founder Mr. Psychedelic Law, Jerry B. Brown, Ph.D. and Julie M. Brown, M.A., L.M.H.C., Paul Austin Founder, CEO Third Wave + Synthesis, Eddie Jacobs Research Fellow, University of Oxford 

Others Details

Time: 9:00 am to 5:00 pm